Legal & General Group
ICVX

Legal & General Group’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Legal & General Group’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,359
Closed -$37.2K – 3394
2023
Q4 		$37.2K Buy
2,359
+128
+6% +$1.23K ﹤0.01% 2852
2023
Q3 		$17.3K Sell
2,231
-416
-16% -$3.45K ﹤0.01% 3092
2023
Q2 		$26.3K Buy
2,647
+694
+36% +$5.55K ﹤0.01% 2996
2023
Q1 		$11.3K Hold
1,953
– – ﹤0.01% 3189
2022
Q4 		$15.5K Hold
1,953
– – ﹤0.01% 3202
2022
Q3 		$6K Hold
1,953
– – ﹤0.01% 3398
2022
Q2 		$11K Sell
1,953
-2,647
-58% -$20.7K ﹤0.01% 3369
2022
Q1 		$32K Buy
4,600
+1,063
+30% +$16.7K ﹤0.01% 3110
2021
Q4 		$81K Buy
3,537
+2,284
+182% +$59K ﹤0.01% 2953
2021
Q3 		$37K Buy
+1,253
New +$42.5K ﹤0.01% 3065

Legal & General Group's ICVX Position: Q1 2024 in Review

Legal & General Group sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 2,359 shares — an estimated $37.2K sold.

Legal & General Group first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $81K in Q4 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Legal & General Group reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Legal & General Group sold 2,359 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $37.2K.
  • Legal & General Group first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Legal & General Group's Icosavax, Inc. Common Stock position peaked at $81K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Legal & General Group's 13F filing for Q1 2024, filed 14 May 2024.